S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.92 (-1.38%)
MSFT   420.85 (-0.14%)
META   488.12 (-1.16%)
GOOGL   150.51 (-0.24%)
AMZN   180.76 (+0.52%)
TSLA   176.29 (-1.97%)
NVDA   905.25 (+0.30%)
NIO   4.61 (-1.28%)
AMD   181.46 (+1.04%)
BABA   72.51 (+1.29%)
T   17.57 (+0.11%)
F   13.28 (+1.68%)
MU   118.47 (-0.56%)
CGC   9.45 (-1.05%)
GE   175.44 (-2.60%)
DIS   122.70 (+1.42%)
AMC   3.69 (-14.98%)
PFE   27.88 (+0.36%)
PYPL   66.82 (+0.38%)
XOM   115.52 (+0.48%)
S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.92 (-1.38%)
MSFT   420.85 (-0.14%)
META   488.12 (-1.16%)
GOOGL   150.51 (-0.24%)
AMZN   180.76 (+0.52%)
TSLA   176.29 (-1.97%)
NVDA   905.25 (+0.30%)
NIO   4.61 (-1.28%)
AMD   181.46 (+1.04%)
BABA   72.51 (+1.29%)
T   17.57 (+0.11%)
F   13.28 (+1.68%)
MU   118.47 (-0.56%)
CGC   9.45 (-1.05%)
GE   175.44 (-2.60%)
DIS   122.70 (+1.42%)
AMC   3.69 (-14.98%)
PFE   27.88 (+0.36%)
PYPL   66.82 (+0.38%)
XOM   115.52 (+0.48%)
S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.92 (-1.38%)
MSFT   420.85 (-0.14%)
META   488.12 (-1.16%)
GOOGL   150.51 (-0.24%)
AMZN   180.76 (+0.52%)
TSLA   176.29 (-1.97%)
NVDA   905.25 (+0.30%)
NIO   4.61 (-1.28%)
AMD   181.46 (+1.04%)
BABA   72.51 (+1.29%)
T   17.57 (+0.11%)
F   13.28 (+1.68%)
MU   118.47 (-0.56%)
CGC   9.45 (-1.05%)
GE   175.44 (-2.60%)
DIS   122.70 (+1.42%)
AMC   3.69 (-14.98%)
PFE   27.88 (+0.36%)
PYPL   66.82 (+0.38%)
XOM   115.52 (+0.48%)
S&P 500   5,254.36 (+0.11%)
DOW   39,777.74 (+0.04%)
QQQ   444.76 (-0.02%)
AAPL   170.92 (-1.38%)
MSFT   420.85 (-0.14%)
META   488.12 (-1.16%)
GOOGL   150.51 (-0.24%)
AMZN   180.76 (+0.52%)
TSLA   176.29 (-1.97%)
NVDA   905.25 (+0.30%)
NIO   4.61 (-1.28%)
AMD   181.46 (+1.04%)
BABA   72.51 (+1.29%)
T   17.57 (+0.11%)
F   13.28 (+1.68%)
MU   118.47 (-0.56%)
CGC   9.45 (-1.05%)
GE   175.44 (-2.60%)
DIS   122.70 (+1.42%)
AMC   3.69 (-14.98%)
PFE   27.88 (+0.36%)
PYPL   66.82 (+0.38%)
XOM   115.52 (+0.48%)
OTCMKTS:CNVVY

ConvaTec Group (CNVVY) Stock Price, News & Analysis

$14.72
-0.23 (-1.54%)
(As of 03/27/2024 ET)
Today's Range
$14.72
$14.72
50-Day Range
$11.51
$14.80
52-Week Range
$9.90
$14.95
Volume
264 shs
Average Volume
11,770 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CNVVY stock logo

About ConvaTec Group Stock (OTCMKTS:CNVVY)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

CNVVY Stock Price History

CNVVY Stock News Headlines

Cooper Companies upgraded at J.P. Morgan on outlook
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
ConvaTec Group goes ex-dividend tomorrow
ConvaTec Group PLC 1H Rev $1.06B
ConvaTec Raises 2023 Sales View
ConvaTec Group PLC FY Rev $2.07B
ConvaTec Group Plc (CNVVF)
Convatec Group PLC: Director/PDMR Shareholding
See More Headlines
Receive CNVVY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:CNVVY
Fax
N/A
Employees
10,136
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Karim Bitar (Age 59)
    CEO & Director
    Comp: $3.74M
  • Mr. Jonathan Peter Mason (Age 60)
    Group CFO & Director
    Comp: $2M
  • Mr. John Haller
    Executive VP and Chief Quality & Operations Officer
  • Dr. Divakar Ramakrishnan Ph.D.
    Executive VP, Chief Technology Officer and Head of Research & Development
  • Ms. Kate Postans
    Vice President of Investor Relations & Corporate Communications
  • Ms. Evelyn Douglas J.D.
    Executive VP, Chief of Corporate Strategy & Business Development and General Counsel
  • Ms. Moyra Withycombe
    Interim Chief People Officer
  • Ms. Kjersti Grimsrud Biotechnology (Age 63)
    M.Sc., President & COO of Infusion Care
  • Mr. David Shepherd
    President & COO of Global Advanced Wound Care
  • Mr. Seth R. Segel (Age 55)
    President and COO of Continence Care & Home Services Group

CNVVY Stock Analysis - Frequently Asked Questions

Should I buy or sell ConvaTec Group stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNVVY shares.
View CNVVY analyst ratings
or view top-rated stocks.

How have CNVVY shares performed in 2024?

ConvaTec Group's stock was trading at $12.56 on January 1st, 2024. Since then, CNVVY shares have increased by 17.2% and is now trading at $14.72.
View the best growth stocks for 2024 here
.

Are investors shorting ConvaTec Group?

ConvaTec Group saw a increase in short interest in March. As of March 15th, there was short interest totaling 500 shares, an increase of 25.0% from the February 29th total of 400 shares. Based on an average trading volume of 500 shares, the days-to-cover ratio is presently 1.0 days.
View ConvaTec Group's Short Interest
.

How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group?

ConvaTec Group declared a dividend on Tuesday, March 26th. Stockholders of record on Friday, April 26th will be paid a dividend of $0.1432 per share on Friday, June 7th. The ex-dividend date of this dividend is Thursday, April 25th. This is a boost from the stock's previous dividend of $0.06.
Read our dividend analysis for CNVVY
.

Is ConvaTec Group a good dividend stock?

ConvaTec Group (OTCMKTS:CNVVY) pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.00%.
Read our dividend analysis for CNVVY.

How do I buy shares of ConvaTec Group?

Shares of CNVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CNVVY) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners